Home » Newsletters » BioWorld Science

BioWorld Science

July 28, 2016

View Archived Issues

Janssen, BMS enter immuno-oncology collaboration in lung cancer

First pivotal trial of intravenous meloxicam achieves primary endpoint

Eisai doses first patient in phase Ib/II study of Halaven plus Halozyme's PEGPH20

Sysmex, Healios and Sumitomo Dainippon partner to develop pre-transplant immune reaction testing

Hisamitsu reports results from phase III study of HP-3060 transdermal system for allergic rhinitis

Pneumococcal vaccination using novel hybrid biological-biomaterial vector

X-Chem and AbbVie form oncology and immunology drug target collaboration

First-in-human trial investigates AGuIX gadolinium-based nanoparticles in brain metastases

Burnet Institute and ARTES Biotechnology to jointly develop HCV vaccine

Neurovance's phase II study of centanafadine in adult ADHD meets endpoints

Beijing Scitech-Mq Pharmaceuticals patents HER1 inhibitors

Phase I study of FluGen's universal influenza vaccine begins

EMA grants PRIME designation to DNX-2401 for recurrent glioblastoma

DPP Zika IgM/IgG assay obtains CE mark for rapid point-of-care detection of Zika virus

Shanghai Institute Materia Medica discloses glucokinase activators

HHS and Yale University develop c-Myc inhibitors

First phase I data for PF-06648671

FDA approves Adlyxin for type 2 diabetes

FTC clears Teva's acquisition of Actavis Generics

Kite Pharma enters license agreement with NIH for fully human anti-CD19 CAR-based product candidate

Pfizer wins auction bid for substantially all of BIND Therapeutics' assets

FDA accepts for review BioMarin's BLA for cerliponase alfa for CLN2 disease

First clinical data for 5-HT-4 receptor partial agonist SUVN-D4010

Cytokinetics and Astellas expand collaboration in skeletal muscle activators

Preclinical profile of novel dual inhibitors of Abeta and tau oligomerization

GSK licenses CNTO-7160 for severe asthma from Janssen

AstraZeneca and Moderna Therapeutics apply to start clinical study of AZD-860 in Germany

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 22, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
Psychedelic space expanding on Trump’s EO
BioWorld
Timothy Leary is dead, but he could be on the outside looking in with a smile on his face as U.S. President Donald Trump’s latest executive order (EO) fuels a...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...
In the clinic for April 21, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Abbott, Agenus, Astrazeneca, Briacell, Clearmind, Greenwich, Intodna,...